Metastatic Pancreatic Adenocarcinoma Treatment, Which One Should be the First Choice, Nab-Paclitaxel Plus Gemcitabine or FOLFIRINOX? A Real Word Data Approach Using Trinetx

Neves Silva, Bruna; Betiol, Julio Cesar

doi:10.5281/zenodo.14555247

Published December 25, 2024 | Version v1

Journal article Open

Metastatic Pancreatic Adenocarcinoma Treatment, Which One Should be the First Choice, Nab-Paclitaxel Plus Gemcitabine or FOLFIRINOX? A Real Word Data Approach Using Trinetx

Files

BJMS-092 - 2025-3(1) - 227-234 - Betiol - Tratamento de Adenocarcinoma Pancreático Metastático, Qual Deve ser a Primeira Escolha, Nab-Paclitaxel Mais Gemcitabina ou Folfiri.pdf

Files (580.8 kB)

Name	Size
BJMS-092 - 2025-3(1) - 227-234 - Betiol - Tratamento de Adenocarcinoma Pancreático Metastático, Qual Deve ser a Primeira Escolha, Nab-Paclitaxel Mais Gemcitabina ou Folfiri.pdf md5:0ed5667ee8b477fba4700fa3221cfe89	580.8 kB	Preview Download

Views

Downloads

Show more details

	All versions	This version
Views	53	53
Downloads	52	52
Data volume	34.9 MB	34.9 MB

More info on how stats are collected....

DOI

Resource type

Journal article

Publisher

Brazilian Journal of Medical Sciences

Published in

Metastatic Pancreatic Adenocarcinoma Treatment, Which One Should be the First Choice, Nab-Paclitaxel Plus Gemcitabine or FOLFIRINOX? A Real Word Data Approach Using Trinetx, 3(1), 227-234, ISSN: 2997-0229, 2024.

License: Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more

Technical metadata

Created: December 25, 2024
Modified: December 25, 2024

Metastatic Pancreatic Adenocarcinoma Treatment, Which One Should be the First Choice, Nab-Paclitaxel Plus Gemcitabine or FOLFIRINOX? A Real Word Data Approach Using Trinetx

Authors/Creators

Files

BJMS-092 - 2025-3(1) - 227-234 - Betiol - Tratamento de Adenocarcinoma Pancreático Metastático, Qual Deve ser a Primeira Escolha, Nab-Paclitaxel Mais Gemcitabina ou Folfiri.pdf

Files (580.8 kB)